Australia's largest stock trading and investment forum Australia's #1 stock forum

PAR

0.00%

25.5¢ paradigm biopharmaceuticals limited..

Hotpy, I think most of the pre revenue (especiallybio) company...

First 463 Last

Share
Profile

Follow
Mangoman605

1,596 Posts.

166

15/12/23

08:35

Post #: 71461927
Share

Originally posted by Hotpy: ↑

exactly my opinion too!

All my pre revenue stocks have dropped 50-90% across the board over the last two years irrespective of good or crap management or sector (although bio's worst hit).
I've seen written multiple times that this is a historic risk off environment, a once in a generation undervaluing of micro caps. money has flooded towards bonds and large caps all over the globe.

I think most people have been looking at this past few years in the wrong light. The risk reward at the moment in these small, pre rev Aussie companies is so much more in our favour now as compared to the last decade. ok I understand there is much more risk in raising capital in the current market but even so I see this as a once in a lifetime opportunity to build large (for me) holdings in multiple companies that I never could have afforded to do if they were fairly valued. I can spread my risk over say 10 risky stocks and now I only need 1 or 2 to come good to be life changing. Just don't panic when you see red. Easy.....

I'm not defending PAR management here but every single hot copper company forum has sounded the same for a long time now. Everyone is bagging management and asking why they've let the stock price drop so far and why are they not doing anything to fix it. In my mind managements job in the current environment is to not go bust. If they can progress the company while not going bust then that's a bonus. Anybody with money, whether that's large companies or brokerages are bulling these small fries left right and centre, they know they hold the power and are taking advantage as much as they can, but at some point in the future sentiment will change and the micro cap market will rally and once it does cash will flood back in and this once in a lifetime buying opportunity will be over and we'll all be back in the boring old green.... probably, maybe, hopefully.

I will say though that some of my companies saw this situation arising and did large cap raises at near all time highs and then did everything they could to preserve funds while waiting for rate cuts and market sentiment to change. PAR is not one of these companies and they have been taken advantage of because of that. Who would have thought hey, doctors are not that good at capital management or predicting once in a generation market fluctuations.

Just my opinion and thank you everyone for keeping the PAR forum relatively civil over these hard times.

Expand

Hotpy, I think most of the pre revenue (especially
bio) company managements grossly exaggerate
their prospects of success. When reality sets in,
the inevitable share price adjustment occurs.
Every biotech I have as a shareholder is guilty of
this. In the case of PAR it is mostly about overly
optimistic timelines, with an eye on the next CR.

It has been said before, but you can only “cry
wolf” so many times before people lose trust
and take what comes out of PR’s mouth as
very unreliable.

PAR Price at posting: 36.0¢ Sentiment: Hold Disclosure: Held
9 Upvote

0 Great analysis

Reply

Top Stories

IVZ

Invictus banks US$5M from Zimbabwean investment fund in support of Cabora Bassa

AZL

Brine and shine: Arizona Lithium wins early stage eco approval to commence wellpad #2 at Prairie

PAM

PAM secures high-grade Chilean copper play in strong territory

BOE

$550 million Jabiluka uranium offer comes unstuck as Government rules lease won't be renewed

BIO

Biome unveils three year revenue target up to $85M – but are 3Y targets enough to excite?

There are more pages in this discussion • 524 more messages in this thread...

First 463 Last

Add PAR (ASX) to my watchlist

(20min delay)
Last 25.5¢		Change 0.000(0.00%)		Mkt cap ! $89.19M

Open	High	Low	Value	Volume
26.0¢	26.0¢	25.0¢	$110.6K	431.0K

Buyers (Bids)

No.	Vol.	Price($)
3	94172	25.5¢

Sellers (Offers)

Price($)	Vol.	No.
26.0¢	30859	5

View Market Depth

No.	Vol.	Price($)
3	94172	0.255
12	382738	0.250
7	113844	0.245
7	91034	0.240
4	78400	0.235

Price($)	Vol.	No.
0.260	15128	2
0.270	500	1
0.275	6347	2
0.290	24580	4
0.295	10000	2

Last trade - 16.10pm 29/07/2024 (20 minute delay)

PAR (ASX) Chart

Hotpy, I think most of the pre revenue (especiallybio) company...

Invictus banks US$5M from Zimbabwean investment fund in support of Cabora Bassa

Brine and shine: Arizona Lithium wins early stage eco approval to commence wellpad #2 at Prairie

PAM secures high-grade Chilean copper play in strong territory

$550 million Jabiluka uranium offer comes unstuck as Government rules lease won't be renewed

Biome unveils three year revenue target up to $85M – but are 3Y targets enough to excite?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Hotpy, I think most of the pre revenue (especiallybio) company...

Top Stories

Invictus banks US$5M from Zimbabwean investment fund in support of Cabora Bassa

Brine and shine: Arizona Lithium wins early stage eco approval to commence wellpad #2 at Prairie

PAM secures high-grade Chilean copper play in strong territory

$550 million Jabiluka uranium offer comes unstuck as Government rules lease won't be renewed

Biome unveils three year revenue target up to $85M – but are 3Y targets enough to excite?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News